Pro resolving inflammatory effects of the lipid mediators of omega 3 fatty acids and its implication in SARS COVID-19

Med Hypotheses. 2020 Dec;145:110340. doi: 10.1016/j.mehy.2020.110340. Epub 2020 Oct 8.

Abstract

COVID-19 is a new disease caused by coronavirus SARS-CoV-2. It was first described in 2019, developed into an epidemic in January 2020 and has spread the global to the present COVID-19 pandemic. Specialized pro‑resolving mediators (SPMs) may play a new role in the management of this lung disease because SPM actively stimulate the resolution of infectious inflammation and are organ protective in animal disease models. Many tissues have been suitable targets for treating inflammation with SPMs or their active precursors 18-HEPE, 17-HDHA and the 14-HDHA, in order to elicit dynamic resolution of inflammation. Here we discuss the possible mode of action of these substances in the management of SARS Covid 19.

Keywords: Inflammation; Resolution; SARS Covid 19; Specialized pro‑resolving mediators.

MeSH terms

  • Animals
  • COVID-19 / immunology*
  • COVID-19 / therapy*
  • Fatty Acids, Omega-3 / chemistry*
  • Humans
  • Inflammation / metabolism*
  • Inflammation Mediators / metabolism*
  • Lipids / chemistry*
  • Models, Theoretical

Substances

  • Fatty Acids, Omega-3
  • Inflammation Mediators
  • Lipids